Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
12.03 BRL | +0.67% | +0.67% | -12.38% |
Mar. 04 | Barclays Downgrades Ambev to Equalweight From Overweight, Adjusts Price Target to $3 From $3.50 | MT |
Feb. 29 | Transcript : Ambev S.A., Q4 2023 Earnings Call, Feb 29, 2024 |
Evolution of the average Target Price on Ambev S.A.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Ambev S.A.
Barclays | |
Jefferies & Co. | |
UBS | |
Bernstein | |
JPMorgan Chase | |
BofA Securities | |
Goldman Sachs | |
Banco Santander | |
Itau BBA | |
Bradesco |
EPS Revisions
- Stock Market
- Equities
- ABEV3 Stock
- Consensus Ambev S.A.